Journal for ImmunoTherapy of Cancer (May 2022)
CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
- Xiangyu Chen,
- Cheng Chen,
- Jun Huang,
- Wei Yao,
- Yanyan Zhang,
- Pengcheng Wang,
- Qing Wu,
- Lisha Wang,
- Yuan Luo,
- Zhiming Wang,
- Minglu Xiao,
- Luoyingzi Xie,
- Guoshuai Cao,
- Shun Lei,
- Zhengping Wei,
- Jingyi Fang,
- Xingxing Yang,
- Qizhao Huang,
- Lifan Xu,
- Junyi Guo,
- Shuqiong Wen,
- Jianfang Tang,
- Jianqiang Ye,
- Ran He,
- Lilin Ye
Affiliations
- Xiangyu Chen
- 1 Department of NCDs Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
- Cheng Chen
- Department of Obstetrics and Gynaecology, Pidu District People’s Hospital, Chengdu, China
- Jun Huang
- 1 Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
- Wei Yao
- Department of Oncology, Albert Einstein College of Medicine, Bronx, New York, USA
- Yanyan Zhang
- Department of Biostatistics and Epidemiology, Shenzhen University Health Science Center, Shenzhen, Guangdong, China
- Pengcheng Wang
- Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, China
- Qing Wu
- Nevada Institute of Personalized Medicine, College of Science, University of Nevada Las Vegas, Las Vegas, Nevada, USA
- Lisha Wang
- 1 State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
- Yuan Luo
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Zhiming Wang
- Research Institute of General Surgery, Jinling Hospital, Medical College of Nanjing University, Nanjing, People’s Republic of China
- Minglu Xiao
- Institute of Immunology, Third Military Medical University, Chongqing, China
- Luoyingzi Xie
- Institute of Immunology, Third Military Medical University, Chongqing, China
- Guoshuai Cao
- Pritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois, USA
- Shun Lei
- Institute of Immunology, Third Military Medical University, Chongqing, China
- Zhengping Wei
- Institute of Immunology, Third Military Medical University, Chongqing, China
- Jingyi Fang
- Institute of Immunology, Third Military Medical University, Chongqing, China
- Xingxing Yang
- Institute of Cancer, Third Military Medical University Second Affiliated Hospital, Chongqing, China
- Qizhao Huang
- School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China
- Lifan Xu
- Institute of Immunology, Third Military Medical University, Chongqing, China
- Junyi Guo
- Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Stomatological Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
- Shuqiong Wen
- Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Stomatological Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
- Jianfang Tang
- Institute of Immunology, Third Military Medical University, Chongqing, China
- Jianqiang Ye
- Key Laboratory of Jiangsu Preventive Veterinary Medicine, Key Laboratory for Avian Preventive Medicine, Ministry of Education, College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, China
- Ran He
- Department of Immunology, Huazhong University of Science and Technology Tongji Medical College School of Basic Medicine, Wuhan, Hubei, China
- Lilin Ye
- Institute of Immunology, Third Military Medical University, Chongqing, China
- DOI
- https://doi.org/10.1136/jitc-2021-004022
- Journal volume & issue
-
Vol. 10,
no. 5
Abstract
No abstracts available.
